Protein arginine methyltransferase 1 (PRMT1) has been implicated in cell cycle progression, DNA repair, innate immunity, and RNA processing and proposed as a therapeutic target in several cancer types [258,259,260]. The gene discussed is PRMT1; the disease is cancer.